· Talking Medicines is today launching its artificial intelligence and natural language processing powered patient intelligence platform, PatientMetRx, to provide a systematic way of measuring the patient experience of medicines for the pharmaceutical industry. · In order to provide Device Authority with further working capital to facilitate its significant pipeline of opportunities, Tern has provided an additional approximately US$0.3 million to Device Authority in the form of a further convertible loan, alongside an additional convertible loan investment of approximately US$0.1 million from Alsop Louie Partners and the George Samenuk Trust. · As at 31 December 2020, Tern had unaudited cash resources of £2.1 million, with approximately £0.38 million subsequently invested in its portfolio companies, Device Authority and Wyld Networks Limited ( Wyld Networks ), as part of their recent syndicated fundraising